Abstract Coronavirus disease 2019 (COVID-19)-associated invasive fungal infections are an
important complication in a substantial number of critically ill, hospitalized patients with …

Infections caused by Aspergillus spp. remain associated with high morbidity and mortality.
While mold-active antifungal prophylaxis has led to a decrease of occurrence of invasive …

It is important to realize that guidelines cannot always account for individual variation among
patients. They are not intended to supplant physician judgment with respect to particular …

The literature regarding COVID-19-associated pulmonary aspergillosis (CAPA) has shown
conflicting observations, including survival of CAPA patients not receiving antifungal therapy …

Invasive aspergillosis (IA) is an increasingly recognised phenomenon in critically ill patients
in the intensive care unit, including in patients with severe influenza and severe coronavirus …

We systematically reviewed and analyzed the available data for galactomannan (GM), β-D-
glucan (BG), and polymerase chain reaction (PCR)–based assays to detect invasive fungal …

Invasive fungal diseases are important clinical problems that are often complicated by
severe illness and therefore the inability to use invasive measures to definitively diagnose …

Invasive mould infections are an increasing cause of morbidity and mortality globally, mainly
due to increasing numbers of immunocompromised individuals at risk for fungal infections …

Detection of galactomannan has become widely available for diagnosing invasive
aspergillosis. The test characteristics, using the Platelia™ enzyme-immunoassay, have …

Invasive Aspergillosis (IA) is one of the most common invasive fungal diseases and is
accompanied by high morbidity and mortality. In order to maximize patient outcomes and …